415
0
Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study
- Title
- Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study
- Author
- 박용수
- Keywords
- Lobeglitazone; Thiazolidinediones; Clinical trial; Randomised trial
- Issue Date
- 2015-07
- Publisher
- Elsevier
- Citation
- Diabetes Research and Clinical Practice, v. 110, NO 3, Page. 27-30
- Abstract
- We aimed to assess the safety and efficacy of lobeglitazone in patients with type 2 diabetes over 52 weeks through 28-week extension study. Clinical benefits in terms of glycemic and lipid control were maintained for 52 weeks. Lobeglitazone showed a favorable balance of efficacy and safety during the extension study.
- URI
- http://www.sciencedirect.com/science/article/pii/S0168822715003824http://hdl.handle.net/20.500.11754/26253
- ISSN
- 0168-8227; 1872-8227
- Appears in Collections:
- COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
- Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
